Tacrolimus (FK506) promotes placentation and maternal-fetal tolerance through modulating FASN-CEACAM1 pathway.

Meng X, Shi M, Qian J, Luo Y, Cui L, Li D, Wang S

Open source

DOI
10.3389/fimmu.2025.1522346
Published
2025
Container
Frontiers in immunology
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2025.1522346,
  title = {Tacrolimus (FK506) promotes placentation and maternal-fetal tolerance through modulating FASN-CEACAM1 pathway.},
  author = {Meng X and Shi M and Qian J and Luo Y and Cui L and Li D and Wang S},
  year = {2025},
  journal = {Frontiers in immunology},
  doi = {10.3389/fimmu.2025.1522346},
  url = {https://doi.org/10.3389/fimmu.2025.1522346}
}

RIS

TY  - JOUR
TI  - Tacrolimus (FK506) promotes placentation and maternal-fetal tolerance through modulating FASN-CEACAM1 pathway.
AU  - Meng X
AU  - Shi M
AU  - Qian J
AU  - Luo Y
AU  - Cui L
AU  - Li D
AU  - Wang S
PY  - 2025
JO  - Frontiers in immunology
DO  - 10.3389/fimmu.2025.1522346
UR  - https://doi.org/10.3389/fimmu.2025.1522346
ER  - 

APA

X, M., M, S., J, Q., Y, L., L, C., D, L., & S, W. (2025). Tacrolimus (FK506) promotes placentation and maternal-fetal tolerance through modulating FASN-CEACAM1 pathway.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2025.1522346

Source records